MARC details
000 -LEADER |
fixed length control field |
04814cam a2200493 i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20211128223227.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
080909s2008 bcca b 000 0 eng d |
011 ## - LINKING LIBRARY OF CONGRESS CONTROL NUMBER [OBSOLETE] |
Local cataloguing issues note |
Direct search result |
011 ## - LINKING LIBRARY OF CONGRESS CONTROL NUMBER [OBSOLETE] |
Local cataloguing issues note |
MARC Score : 8700(21850) : SubPar |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
1425168094 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781425168094 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)263469268 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
NLC |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
NLC |
Modifying agency |
YDXCP |
-- |
EYP |
-- |
SCB |
-- |
OCLCF |
-- |
OCLCQ |
-- |
NLC |
-- |
OCLCO |
-- |
OCLCA |
-- |
ATU |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.4624 |
Edition number |
23 |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
Classification number |
616.4624 KRA |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Kraft, Joseph R., |
Relator term |
author. |
245 10 - TITLE STATEMENT |
Title |
Diabetes epidemic & you / |
Statement of responsibility, etc. |
Joseph R. Kraft. |
246 3# - VARYING FORM OF TITLE |
Title proper/short title |
Diabetes epidemic and you |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Victoria, BC : |
Name of producer, publisher, distributor, manufacturer |
Trafford, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2011] |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Date of production, publication, distribution, manufacture, or copyright notice |
©2011 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xi, 110 pages : |
Other physical details |
illustrations ; |
Dimensions |
23 cm |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Part 1: The evolution of the diabetes epidemic -- American Diabetes Association and Department of Health and Human Services screening recommendations -- Fasting blood sugar: what is normal? -- Diabetes in ancient times -- Hippocrates: the father of medicine -- Diabetes history: sixteenth to nineteenth centuries -- Discovery of insulin -- The Yalow-Berson contribution: the radioimmunoassay of insulin -- The Atomic Energy Act of 1945 and laboratory medicine -- Oak Ridge Institute of Nuclear Studies -- History of the insulin assay St. Joseph Hospital, Chicago, Illinois 1972-1998 --Normal fasting insulin: what is normal? -- Dynamic insulin patterns -- The oral glucose tolerance: 1918-2007 -- Pathology of type 2 diabetes -- Hyperinsulinemia: clinical pathology -- Functional hypoglycemia: clinical fact or fiction? -- Gestational diabetes -- C-Reactive protein -- Cholesterol: a rsk factor for heart disease and diabetes? -- Overweight/obese: a risk factor for heart disease and diabetes -- Know your risk factors for heart disease and diabetes -- The metabolic syndrome: what is it? -- Diabetes and idiopathic cardiomyopathy -- Hyperinsulinemia vs. insulin resistance -- Part 2: Age distribution of 14,384 oral glucose tolerances with insulin assays -- Diabetes: a worldwide plague: facing the challenge. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
DIABETES EPIDEMIC and YOU is not a cliche! It is a mandate for the awakening of the "silent" millions worldwide with "normal" fasting blood sugars and undiagnosed diabetes. If you have a "normal" fasting blood sugar, YOU may be one of the undiagnosed millions. YES, I do mean YOU. Since Hippocrates' time, earliest diagnosis provided the greatest opportunity for treatment and cure. This book highlights the earliest identification of type 2 diabetes by utilizing the insulin assay with the oral glucose tolerance. My cumulative experience of 14,384 oral glucose tolerances with insulin assays established the earliest diagnosis of prediabetes and diabetes when the blood sugars were normal. Prediabetes is type 2 diabetes. The tolerances were separated according to age groups, from 3-13 years to 81-90+ years. Each group was further divided into normal glucose tolerances, impaired glucose tolerances, and diabetes mellitus glucose tolerances. YOU, upon testing by oral glucose tolerance, will be in one of these categories. This resource of oral glucose tolerance with insulin assay is unequaled in world medical literature. The importance of early diagnosis is that the clinical pathology of diabetes - mainly heart disease, high blood pressure, stroke, cataracts, erectile dysfunction, and other metabolic disorders - occurs not only in those with advanced diabetes, but also in those with "normal" blood sugars. YES, this could happen to YOU! When early diagnosis is coupled with specific therapy, the DIABETES EPIDEMIC will be arrested and then reversed. Early diagnosis is the goal of this book - beginning with YOU. |
588 ## - SOURCE OF DESCRIPTION NOTE |
Source of description note |
Machine converted from AACR2 source record. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Non-insulin-dependent diabetes. |
9 (RLIN) |
321450 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Non-insulin-dependent diabetes |
General subdivision |
Pathogenesis. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Glucose tolerance tests. |
9 (RLIN) |
385294 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Insulin resistance. |
9 (RLIN) |
319410 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Blood sugar. |
9 (RLIN) |
374582 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Diabetes |
General subdivision |
Diagnosis |
9 (RLIN) |
790285 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Prediabetic state. |
9 (RLIN) |
351820 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Diabetes Mellitus, Type 2. |
9 (RLIN) |
362669 |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
a |
.b27211757 |
b |
06-09-21 |
c |
09-08-19 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Book |
945 ## - LOCAL PROCESSING INFORMATION (OCLC) |
a |
616.4624 KRA |
g |
0 |
i |
A566642B |
j |
0 |
l |
cmain |
o |
- |
p |
$0.00 |
q |
- |
r |
- |
s |
- |
t |
0 |
u |
0 |
v |
0 |
w |
0 |
x |
0 |
y |
.i13642212 |
z |
09-08-19 |
945 ## - LOCAL PROCESSING INFORMATION (OCLC) |
a |
616.4624 KRA |
g |
0 |
i |
A566646B |
j |
0 |
l |
smain |
o |
- |
p |
$0.00 |
q |
- |
r |
- |
s |
- |
t |
0 |
u |
1 |
v |
3 |
w |
1 |
x |
0 |
y |
.i13642224 |
z |
09-08-19 |
945 ## - LOCAL PROCESSING INFORMATION (OCLC) |
a |
616.4624 KRA |
g |
0 |
i |
A566617B |
j |
0 |
l |
nmain |
o |
- |
p |
$0.00 |
q |
- |
r |
- |
s |
- |
t |
0 |
u |
0 |
v |
0 |
w |
0 |
x |
0 |
y |
.i13642236 |
z |
09-08-19 |
998 ## - LOCAL CONTROL INFORMATION (RLIN) |
-- |
(2)b |
-- |
(2)c |
-- |
(2)n |
-- |
(2)s |
Operator's initials, OID (RLIN) |
09-08-19 |
Cataloger's initials, CIN (RLIN) |
m |
First date, FD (RLIN) |
a |
-- |
eng |
-- |
bcc |
-- |
0 |